Viewing Study NCT04732364



Ignite Creation Date: 2024-05-06 @ 3:43 PM
Last Modification Date: 2024-10-26 @ 1:55 PM
Study NCT ID: NCT04732364
Status: UNKNOWN
Last Update Posted: 2021-02-01
First Post: 2021-01-06

Brief Title: Analgesic Efficacy of Ultrasound Guided Erector Spinae Block for Modified Radical Mastectomy
Sponsor: South Egypt Cancer Institute
Organization: South Egypt Cancer Institute

Study Overview

Official Title: Analgesic Efficacy of Magnesium Sulphate as an Adjuvant to Levo-bupivacine in Ultrasound Guided Erector Spinae Plan Block for Modified Radical Mastectomy
Status: UNKNOWN
Status Verified Date: 2021-01
Last Known Status: ENROLLING_BY_INVITATION
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To compare the analgesic efficacy of dexmedetomidine and magnesium sulphate as adjuvants to levobupivacaine in erector spinae plane block in modified radical mastectomy surgery for acute and chronic pain management
Detailed Description: 3 groups

Group C I20 patient control group

Patients will receive 20 ml 025 levobupivacaine into the interfascial plane below erector spinae muscle at level of T5

Group D II 20 patient Dexmetonidine group

Patient will receive 20ml 025 levobupivacaineas above 1μkg dexmedetomidine

Group M III 20 patient magnesium slphate group

Patient will receive 20ml 025 levobupivacaineas above 07 mgkg MgSo4 The patient the anesthesiologist who administered the drugs and the data collector will be blinded to the study drugs

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None